BioCentury
ARTICLE | Clinical News

Accelr8 Technology preclinical data

November 10, 2008 8:00 AM UTC

In 126 bacterial strains, Accelr8's ESBL test had 96% sensitivity and 96% specificity in detecting extended-spectrum beta lactamase (ESBL)-resistant bugs. The test produced results in 90-180 minutes....